EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
3.1.4.53 | Neoplasms |
175089 |
The content and metabolism of cyclic adenosine 3', 5'-monophosphate and cyclic guanosine 3', 5'-monophosphate in adenocarcinoma of the human colon. |
causal interaction diagnostic usage unassigned |
1 2 0 |
3.1.4.53 | Carcinoma, Hepatocellular |
199292 |
[Concentration and metabolism of cyclic AMP during the early stages of hepatoma 22a growth] |
ongoing research unassigned |
1 0 |
3.1.4.53 | Neoplasms |
207518 |
Cyclic AMP-binding proteins: inverse relationship with estrogen-receptors in hormone-dependent mammary tumor regression. |
causal interaction diagnostic usage unassigned |
4 1 0 |
3.1.4.53 | Sarcoma |
212566 |
Nucleases and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in murine sarcoma virus (Moloney)-infected mice. |
causal interaction ongoing research unassigned |
1 3 0 |
3.1.4.53 | Virus Diseases |
212566 |
Nucleases and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in murine sarcoma virus (Moloney)-infected mice. |
causal interaction ongoing research unassigned |
1 3 0 |
3.1.4.53 | Herpes Zoster |
217676 |
Studies on cyclic nucleotides in the adrenal gland. VIII. Effects of angiotensin on adenosine 3',5'-monophosphate and steroidogenesis in the adrenal cortex. |
diagnostic usage therapeutic application unassigned |
3 2 0 |
3.1.4.53 | Cholera |
1338391 |
Decreased phosphodiesterase activity in cholera toxin-induced hypersecretion in suckling rats. |
unassigned |
0 |
3.1.4.53 | Myocardial Infarction |
1376823 |
Inhibition of granulocyte cAMP-phosphodiesterase by rolipram in vivo is not sufficient to protect the canine myocardium from reperfusion injury. |
ongoing research therapeutic application unassigned |
4 4 0 |
3.1.4.53 | Reperfusion Injury |
1376823 |
Inhibition of granulocyte cAMP-phosphodiesterase by rolipram in vivo is not sufficient to protect the canine myocardium from reperfusion injury. |
ongoing research therapeutic application unassigned |
4 4 0 |
3.1.4.53 | Diabetes Mellitus |
1497693 |
Effects of the anti-platelet agent cilostazol on peripheral vascular disease in patients with diabetes mellitus. |
ongoing research therapeutic application unassigned |
3 4 0 |